Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2004 Jun;113(12):1681-3.
doi: 10.1172/JCI22153.

Is transplantation tolerable?

Terry B Strom  1
Affiliations
Comment

Is transplantation tolerable?

Terry B Strom. J Clin Invest. 2004 Jun.

Abstract

To test the hypothesis that chronic stimulation of T cells with a weak agonistic antigen will generate regulatory T cells and immune tolerance, a study reported in this issue employed the redesign of a minor histocompatibility antigen. Using knowledge of residues at which the antigen contacts the T cell receptor, a weak agonist was produced. Pretreatment with this altered antigen produced transplant tolerance, generation of regulatory T cells, and a loss of many antigen-reactive T cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
As compared with antigenic stimulation (A), stimulation of female transgenic mice with an APL of the Dby minor histocompatibility (mH) antigen, which delivers incomplete signals to naive T cells, (a) promotes the production of Foxp3+ regulatory T cells, (b) limits the development of effector T cells, and (c) magnifies the apoptotic loss of activated T cells (B), resulting in tolerance to male skin grafts. Ag, antigen.
See this image and copyright information in PMC

Comment on

References

    1. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 1970;18:723–735. - PMC - PubMed
    1. Hall B, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med. 1990;171:141–157. - PMC - PubMed
    1. Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J. Exp. Med. 1985;161:123–133. - PMC - PubMed
    1. Hendry WS, et al. Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer. J. Exp. Med. 1979;149:1042–1055. - PMC - PubMed
    1. Chen T-C, Waldmann H, Fairchild PJ. Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby. J. Clin. Invest. 2004;113:1754–1762. doi:10.1172/JCI200420569. - PMC - PubMed

Substances